Viewing Study NCT07231458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:18 AM
Ignite Modification Date: 2026-05-16 @ 3:25 AM
Study NCT ID: NCT07231458
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2025-11-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies
Sponsor: Abalos Therapeutics GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-oncolytic virus View
None Arenavirus View
None Immunotherapy View